Gonadorelin

Gonadorelin is a synthetic GnRH peptide studied for pituitary LH and FSH stimulation, reproductive support, and endogenous sex-hormone signaling.

Profile · 01

Overview

Gonadorelin is a synthetic decapeptide identical to endogenous gonadotropin-releasing hormone (GnRH). It is FDA-approved in diagnostic use for pituitary gonadotroph evaluation, while broader wellness and testosterone-optimization use remains more extrapolative.

The source protocol emphasizes pulsatile, non-daily dosing rather than continuous stimulation, because prolonged daily exposure can desensitize GnRH receptors and reduce the very LH/FSH response the peptide is meant to support.

At a Glance

Goal

Support physiologic LH and FSH release for reproductive and endogenous sex-hormone signaling

Protocol

Suggested non-consecutive weekly titration approach with lower starting doses and gradual increase.

Reconstitute

Add 2.0 mL bacteriostatic water to a 2 mg vial for 1 mg/mL concentration

Typical dose range

50-250 mcg per injection, 2-3 times weekly

Start

50-100 mcg per injection during Weeks 1-2

Target

100-150 mcg per injection by Weeks 5-8

Frequency

2-3 times weekly on non-consecutive days (subcutaneous)

Cycle Length

4-8 weeks with time off to preserve sensitivity

Timing

Morning injections are commonly preferred; rotate sites

Route

Subcutaneous

Cycle

4-8 weeks on, 4 weeks off

Inject two to three times weekly on non-consecutive days to preserve the physiologic, pulsatile character of GnRH signaling. The source explicitly warns against continuous daily use because receptor desensitization can lead to reduced LH and FSH output.

Dose progression

Weeks 1-2

50 mcg (0.05 mg) · 5 units (0.05 mL)

Weeks 3-4

100 mcg (0.1 mg) · 10 units (0.10 mL)

Weeks 5-8

100-150 mcg (0.1-0.15 mg) · 10-15 units (0.10-0.15 mL)

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Science · 01

How Gonadorelin works.

Gonadorelin is identical to endogenous GnRH and stimulates pituitary gonadotrophs to release LH and FSH when delivered in a pulsatile pattern. That makes it conceptually different from downstream compounds like hCG, which act directly at the gonadal receptor level.

The source and literature both emphasize a key constraint: continuous or overly frequent GnRH signaling can desensitize receptors and suppress the intended output. That is why intermittent scheduling is central to the protocol design.

Science · 02

Effects

Observations from clinical or preclinical literature.

Supports endogenous LH and FSH release through hypothalamic-pituitary signaling

May support testosterone production and spermatogenesis when the upstream axis is still responsive

Has legitimate clinical grounding in diagnostic and reproductive-endocrinology contexts

Generally well tolerated in monitored clinical settings

Mild injection-site irritation, headache, or flushing may occur

Overly continuous use may reduce responsiveness through receptor desensitization

Science · 03

Caution

Use caution in hormone-sensitive cancers or complex reproductive endocrine disorders

Not recommended during pregnancy or breastfeeding outside direct specialist supervision

Avoid continuous daily use beyond brief windows because receptor desensitization can become counterproductive

Consult a qualified healthcare provider before use if you are already on hormone therapy or fertility treatment

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Lifestyle · 01

CoFactors

Zinc

Supports testosterone production and broader reproductive physiology.

Vitamin D

Relevant to hormonal balance and reproductive health.

Magnesium

Supports enzymatic processes involved in steroidogenesis and recovery.

Omega-3 fatty acids

Support broader inflammatory and hormonal health.

Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Prioritize sleep because reproductive-hormone rhythms are sensitive to sleep disruption

Use resistance training and balanced nutrition to support endocrine function

Manage stress because chronic cortisol elevation can impair HPG-axis signaling

Limit alcohol and reduce endocrine-disruptor exposure where possible

Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

Testosterone levels and symptoms - track libido, mood, and energy trends
LH and FSH response - important when monitoring upstream axis responsiveness
Testicular function or fertility markers - useful where those are the target outcome
Injection-site reactions - note redness, swelling, or discomfort

Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

Total and free testosterone

Primary downstream sex-steroid markers.

LH and FSH

Direct measures of pituitary response to the protocol.

Estradiol

Useful when testosterone production increases substantially.

CBC (Complete Blood Count)

General monitoring and baseline screening.

CMP (Comprehensive Metabolic Panel)

Assess broader systemic function during the protocol.

Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length

Vial size

Bac. water

Syringe

Vials

0 × 2 mg each…

Syringes

Bac. water

0 mL

Swabs

02 per syringe

Calculators · 02

Dose Calculator

Vial

Bac. water

Syringe

Dose

Concentration

0mcg/mL

Volume per dose

0mL

…

Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

Allow vial to reach room temperature for 15–20 minutes before reconstitution.
Draw the chosen bacteriostatic water volume with a sterile syringe.
Inject slowly down vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Use within 30 days; discard any unused solution after 30 days.

Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and injection site with alcohol and allow them to dry

Pinch a skinfold and insert the needle at 45-90 degrees into subcutaneous tissue

Do not aspirate for subcutaneous injections; inject slowly and steadily

Rotate sites systematically across the abdomen, thighs, and upper arms

Discard used syringes immediately in a sharps container

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Practice · 03

Storage

Lyophilized

Store at room temp in dry, dark conditions; minimize moisture exposure.

Reconstituted

Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.

Reference · 01

Notes

Use a new sterile insulin syringe for each injection and dispose of it safely

Non-consecutive dosing matters because this peptide can lose effect with overly continuous exposure

Morning scheduling is commonly used, but consistency is more important than a perfect clock time

Hormone-monitoring protocols should involve qualified healthcare providers

PepTribe is an educational platform. This information is for research and learning purposes only and is not medical advice.

Reference · 02

References

NCBI Bookshelf
Gonadorelin pharmacology, clinical uses, and diagnostic context.
https://www.ncbi.nlm.nih.gov/books/NBK519514/
PubMed
Belchetz et al., pituitary responses to continuous and intermittent GnRH delivery.
https://pubmed.ncbi.nlm.nih.gov/6766450/
PMC
GnRH application in hypogonadotropic hypogonadism.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3214853/
Mayo Clinic
Gonadorelin proper-use information.
https://www.mayoclinic.org/drugs-supplements/gonadorelin-subcutaneous-route-injection-route/proper-use/drg-20064076
CDC
Subcutaneous injection route guidance.
https://www.cdc.gov/vaccines/hcp/admin/downloads/YCTS-VaxAdmin-Subcut-injection.pdf